The antibacterial activity of extracts of nine plant species with good activity against Escherichia coli against five other bacteria and cytotoxicity of extracts by Ishaku Leo Elisha et al.
RESEARCH ARTICLE Open Access
The antibacterial activity of extracts of nine
plant species with good activity against
Escherichia coli against five other bacteria
and cytotoxicity of extracts
Ishaku Leo Elisha1,2, Francien S. Botha1, Lyndy Joy McGaw1 and Jacobus Nicolaas Eloff1*
Abstract
Background: The development of antibiotic resistant bacteria stems from a number of factors, including inappropriate
use of antibiotics in human and animal health and their prolonged use as growth promoters at sub-clinical doses in
poultry and livestock production. We were interested in investigating plants that could be useful in protecting humans or
animals against diarrhoea. We decided to work on extracts of nine plant species with good activity against Escherichia coli
based on earlier work in the Phytomedicine Programme. Leaves of nine medicinal plant species with high antibacterial
activity against Escherichia coli were extracted with acetone and their minimal inhibitory concentration (MIC) values
determined using a microplate serial dilution technique against Gram-positive (Staphylococcus aureus, Enterococcus faecalis
and Bacillus cereus) and Gram-negative (Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa) bacteria.
Bioautography was used to determine the number of bioactive compounds in each extract. In vitro safety of the extracts
was determined using the 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide reduction assay on Vero cells.
Results: The extracts were active against all the pathogens with average MICs ranging from 0.02 to 0.52 mg/ml.
As expected E. coli was relatively sensitive, while E. faecalis and S. Typhimurium were more resistant to the
extracts (average MICs of 0.28 mg/ml and 0.22 mg/ml respectively). Cremaspora triflora and Maesa lanceolata leaf
extracts had higher activity than the other extracts against Gram-positive and Gram-negative pathogens with
mean MICs of 0.07 mg/ml and 0.09 mg/ml respectively. Extracts of Maesa lanceolata and Hypericum roeperianum
had the highest total antibacterial activity (TAA) at 1417 and 963 ml/g respectively. All extracts with the exception of that
of Maesa lanceolata, Elaeodendron croceum and Calpurnia aurea had relatively low cytotoxicity with LC50 > 20 μg/ml.
Cremaspora triflora had the best selectivity index (SI) against S. aureus and E. coli of 2.87 and 1.15 respectively. Hypericum
roeperianum had a SI of 1.10 against B. cereus. Bioautography revealed 1–6 visible antimicrobial compounds that were
generally non-polar.
Conclusions: There was a weak positive, but statistically non-significant correlation between the potency of the extracts
and their cytotoxicity (R = 0.45, ρ > 0.05). The activity of the extracts on the test bacteria was in some cases not correlated
with cytotoxicity, as shown by selectivity indices >1. This means that cellular toxicity was probably not due to compounds
with antibacterial activity. Some of the extracts had a good potential for therapeutic use against the bacterial pathogens
or for application in treating diarhoea. It does not appear that activity against E. coli is a good predictor of activity against
Gram-negative rather than Gram-positive bacteria. Further investigation is in progress on C. triflora and H. roeperianum,
both of which had promising activities and potential safety based on cytotoxicity.
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Background
Rising antibiotic resistanceand the scarcity of new
antimicrobialshas long beenacknowledged [1, 2]. A
major challenge in global health care is the need for
novel, effective and affordable medicines to treatmicro-
bial infections, especially in developing countries of the
world, where up to one-halfof deathsare due to infec-
tious diseases [3, 4].
Some Staphylococcus spp. and Streptococcus spp. in-
volved in the pathogenesis of respiratory and skin infec-
tions, along with Pseudomonads and members of the
Enterobacteriaceae causing gastrointestinal, urogenital dis-
eases and wound contamination are resistant to virtually
all of the older antibiotics [5]. Clinical isolates of Staphylo-
coccus aureus, the leading cause of nosocomial infections,
are increasingly resistant to an array of antimicrobial
agents like penicillin, gentamicin, tobramycin, amikacin,
ciprofloxacin, clindamycin, erythromycin, chlorampheni-
col, trimethoprim-sulfamethoxazole and vancomycin [6].
The development of antimicrobial-resistant bacterial
species stems from a number of factors which include
the prevalent and sometimes inappropriate use of antibi-
otics, extensive use of these agents as growth enhancers
in animal feed, and increased transboundary passage of
antibiotic-resistant bacteria [6]. The problem of anti-
biotic resistance in humans and animals will continue
for a long time [7]. Against this backdrop, the develop-
ment of alternative drug classes to treat such infectious
diseases is urgently required [4].
Plants have an amazing ability to produce a wide variety
of secondary metabolites, like alkaloids, glycosides, terpe-
noids, saponins, steroids, flavonoids, tannins, quinones
and coumarins [8]. These biomolecules are the source of
plant-derived antimicrobial substances (PDAms) [4]. Some
natural products are highly efficient in the treatment of
bacterial infections [9].
South Africa has a large diversity of plant species
containing many useful bioactive constituents [10, 11].
The lack of access to Western primary health care and
veterinary services in many rural parts of the world has
helped sustain the use of traditional medicine to treat
both humans and animals. Even where orthodox medi-
cines are readily available, a large percentage of the
population still use herbal remedies along with or in
preference to conventional medicines [12].
We are interested in applying plant extracts to treat
diarhoea in humans and animals. Because E. coli plays
an important role in causing diarrhoea, we selected nine
species (Hypericum roeperianum, Cremaspora triflora,
Heteromorpha arborescens, Pittosporum viridiflorum,
Bolusanthus speciosus, Calpurnia aurea, Maesa lanceo-
lata, Elaeodendron croceum and Morus mesozygia) from
the Phytomedicine database of the University of Pretoria
that had good activity against E. coli [13]. Traditional
use was not taken into aaccount in selecting these species.
Here we discuss the in vitro antibacterial activity of
acetone leaf extracts of these nine different South African
plant species against three Gram-positive and three
Gram-negative bacteria (Staphylococcus aureus, Entero-
coccus faecalis, Bacillus cereus, Pseudomonas aeruginosa,
Salmonella Typhimurium, and Escherichia coli). We de-
termined the number of antibacterial compounds present
in extracts by bioautography and the correlation between
cytotoxicity and potency against Gram-negative and
Gram-positive bacteria. We also determined whether
extracts with high activity against Gram-negative bac-
teria would have higher activity against other Gram-
negative bacteria than against Gram-positive bacteria.
Methods
Collection of plant material, drying and storage
The leaves of Hypericum roeperianum G.W. Schimp.exA.
Rich. var. Roeperianum, (Hypericaceae, PRU 120126),
Cremaspora triflora (Thonn.) K.Schum (Rubiaceae, PRU
120129), Heteromorpha arborescens (Spreng.) Chan.
&Schltdl (Apiaceae, PRU 120026), Pittosporum viridi-
florum Sims (Pittosporaceae, PRU 120025), Bolusanthus
speciosus (H. Bolus) Harms (Fabaceae, PRU 120027),
Calpurnia aurea (Aiton) Benth ssp aurea (Fabaceae,
PRU 120125), Maesa lanceolata Forssk (Maesaceae
PRU120125), Elaeodendron croceum (Thunb.) DC
(Celastraceae, PRU 120127) and Morus mesozygia Stapf
ex A.Chev (Moraceae, PRU 120128) were collected in
the summer of 2013, at the University of Pretoria
Botanical Garden, Pretoria National Botanical Garden
and Lowveld National Botanical Garden in Nelspruit,
Mpumalanga Province South Africa. Voucher specimens
were prepared and deposited in the HGWJ Schweickerdt
Herbarium of the University of Pretoria (PRU).
Methods developed in the Phytomedicine Programme
were used [13]. Leaves were examined and those attacked
by insects or microbes were removed. Harvested leaves
were stored in open mesh loosely woven bags to ensure
airflow for quick drying indoors at room temperature to
minimise chemical changes by microbial attack after col-
lection. The leaves were ground to a fine powder using a
Jankel and Künkel Model A10 mill. The powder was
stored in tightly closed glass containers in the dark at
room temperature.
Extraction
Acetone (technical grade, Merck) was used as an extract-
ant in the assays using a ratio of 1:10 of leaf material to ex-
tractant. Acetone is the best choice as an extractant
mainly due to its ability to extract compounds of a wide
range of polarities [14, 15], its low toxicity to bioassay sys-
tems [16] and because it is easy to remove from extracts.
Three grams (3.0 g) of each tree leaf sample was extracted
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with 30 ml acetone. The resulting suspension was shaken
vigorously in 50 ml polyester centrifuge tubes and centri-
fuged at 4000 x g for 10 min (Hettich Centrifuge, Rotofix
32A, Labotec, Johannesburg, South Africa). The superna-
tants were decanted into preweighed glass vials through
Whatman No. 1 filter paper and concentrated to dryness
under a stream of cold air. The dried extracts were made
up to a concentration of 10 mg/ml (stock solution) in
acetone to be used in subsequent assays and stored at 5 °C
in tightly stoppered glass tubes.
Thin layer chromatography (TLC) analysis of the extracts
Three solvent systems with differing polarities were used
to analyse 100 μg of the extract placed in a band of 1 cm
by thin layer chromatography (Merck aluminium-backed
plates, silica gel 60 F254) [14]. These were benzene: ethanol:
ammonium hydroxide (90:10:1, BEA, non-polar basic),
chloroformethylacetate: formic acid (5:4:1, CEF, intermedi-
ate polarity, acidic) and ethylacetate: methanol: water
(40:5.4:5, EMW, polar, neutral). Visible bands were marked
under daylight and ultraviolet light (254 nm and 360 nm
wavelengths, Camac universal UV light lamp TL-600) be-
fore spraying with freshly prepared vanillin (0.1 g vanillin,
28 ml methanol, 1 ml sulphuric acid) spray reagent [17].
The plates were carefully heated at 105 °C for optimal
colour development.
Test organisms
Microorganisms used in this study represent pathogenic
species commonly associated with nosocomial infec-
tions. The bacteria were maintained in the Phytomedi-
cine Laboratory at Onderstepoort, University of Pretoria
and consisted of three Gram-positive strains, E. faecalis
(ATCC 29212), B. cereus (ATCC 21366) and S. aureus
(ATCC 29213), and three Gram-negative strains, E. coli
(ATCC 25922), S. Typhimurium (ATCC 39183) and P.
aeruginosa (ATCC 27853). All the bacterial strains were
subcultured from the original culture, stored at −70 °C
and maintained on Müller-Hinton (MH) agar plates at
4 °C, and grown at 37 °C when required. The strains used
are those recommended by the United States National
Committee for Clinical Laboratory Standardsto compare
antibiotics [18].
Qualitative antibacterial activity assay by bioautography
The bioautography procedure described by Begue and
Kline [19] was used to determine the number of anti-
microbial compounds separated by TLC. Thin layer
chromatography plates were prepared and developed in
the different solvent systems, dried overnight under a
stream of air to remove residual solvent, which might in-
hibit bacterial growth. One of the plates was sprayed
with vanillin spray reagent and the others with two bac-
terial cultures –S. aureus (ATCC 29213) and E. coli
(ATCC 25922). These bacterial species are the major
cause of nosocomial infections in the hospitals [20]. Ten
ml of a dense fresh bacterial culture was centrifuged at
4000 x g for 15 min to concentrate the bacteria. The
supernatant was discarded and the combined pellets re-
suspended in 2–4 ml of fresh Müller-Hinton broth. The
plates were sprayed with the concentrated suspension
until they were just wet, dried in air to remove excess
liquid and incubated overnight at 37 °C at 100% relative
humidity. After incubation, plates were sprayed with a
2 mg/ml solution of p-iodonitrotetrazolium violet (Sigma
chemicals). Clear zones on the chromatograms indicated
inhibition of growth by separated antimicrobial com-
pounds after incubating for about 1–2 h at 37% under
100% relative humidity [19].
Quantitative antibacterial activity assay by minimum
inhibitory (MIC) and total activity
A widely accepted sensitive serial dilution microplate
method [21] was used to determine the minimum in-
hibitory concentration (MIC) of the plant extracts
against six bacterial strains in triplicate. This biological
assay was chosen because of its simplicity, reproducibility,
sensitivity, and relatively low cost while being a rapid
method at the same time. Bacterial cultures grown over-
night were adjusted to McFarland standard 1, equivalent to
3.0 x 108 cfu/ml (Staphylococcus aureus), 2.1 x108cfu/ml
(Enterococcus faecalis), 1.3 x 108 cfu/ml (Bacillus cereus),
3.7 x 108 cfu/ml (Escherichia coli), 3.5 x 108 cfu/ml
(Salmonella typhimurium) and 3.2 x 108 cfu/ml (Pseudo-
monas aeruginosa). The dried extracts were dissolved in
acetone to a concentration of 10 mg/ml and 100 μl was
added to the first well of a 96-well microtitre plate and seri-
ally diluted 1:1 with water. Bacterial cultures (100 μl) were
added to each well. Starting with an extract concentra-
tion of 10 mg/ml, the bacteria were therefore subjected
to final concentrations of 2.5 to 0.02 mg/ml.Gentamicin
was used as positive control and acetone was used as
asolvent control. The highest concentration the bacteria
were subjected to was 25% acetone in the first well and
decreased two-fold in each subsequent well. The
growth of bacteria has never been inhibited by 25%
acetone. Acetone had an MIC of 51% against six fungi
followed by dimethylsulphoxide (45%), methanol (32%)
and ethanol (30%) [16].
The microplates were incubated overnight at 37 °C
in 100% relative humidity. As an indicator of growth,
40 μl of 0.2 mg/ml INT (p-iodonitrotetrazolium vio-
let, Sigma®) dissolved in hot water was then added
to the microplate wells and incubated at 37 °C for
2 h. The MIC was determined visually as the lowest
concentration that led to growth inhibition after c.
2 h.
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Cytotoxic activity
The cytotoxicity of the acetone extracts against Vero
monkey kidney cells was determined by using the 3-(4,5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT) reduction assay as previously described by Mos-
mann [22] with slight modifications. Cells were seeded
at a density of 1 x 105 cells/ml (100 μl) in 96-well micro-
titre plates and incubated at 37 °C and 5% CO2 in a
humidified environment. After overnight incubation,
100 μl each of varying extract concentrations were
added to the wells containing cells. Doxorubicin was
used as a positive reference. A suitable blank control
with equivalent concentrations of acetone was also in-
cluded and the plates were incubated for 48 h in a CO2
incubator. Thereafter, the medium in each well was aspi-
rated from the cells, cells were washed with PBS, and
finally 200 μl fresh media was added to each well. Thirty
microlitres of MTT (5 mg/ml in PBS) was added to each
well and the plates were incubated at 37 °C for 4 h. The
medium was aspirated from the wells and DMSO was
added to solubilise the formazan crystals. The absorb-
ance was measured using a BioTek Synergy microplate
reader at 570 nm. The percentage of cell growth inhibi-
tion was calculated based on a comparison with un-
treated cells. The selectivity index values were calculated
by dividing cytotoxicity LC50 values by the MIC values
of the test bacteria in the same units (SI = LC50/MIC).
Statistical analysis
The experimental results were expressed as mean ± stand-
ard deviation (SD) of three replicates. Where applicable,
the data were subjected to one-way analysis of variance
(ANOVA) and differences between samples were deter-
mined by two-tailed t-test after Bonferroni error correc-
tion of the predictive value. P values less than 0.05 were
considered statistically significant. Microsoft Excel 2010
statistical package was used for all analyses.
Results and discussion
Plant extracts yield
Acetone extraction gave different extraction yields.
Hypericum roeperianum had the highest yield (12%),
followed by Maesa lanceolata (11.12%). The lowest ex-
traction yield was obtained with Morus mesozygia
1.85% (Table 1). These yields were more or less in line
with extract yields from 27 Combretaceae species [23].
Extraction yield from a plant has a great effect on the
overall efficacy and selection for bioprospecting and in
the calculation of total activity [24].
Bioautography
The non-polar BEA solvent system separated the active
bands against S. aureus better than the other solvent sys-
tems, indicating that the bioactive compounds are
relatively non-polar. The retention factor (Rf ), was calcu-
lated by dividing the distance moved by the compound
by the distance of the solvent front. This represents the
position of antimicrobial constituents on the chromato-
gram [25]. The highest number of active bands (6)
against S. aureus bioautography was present in the in H.
roeperianum (Rf = 0.12, 0.27, 0.38, 0.52, 0.67, 0.94) and
M. mesozygia extracts (Rf = 0.09, 0.12, 0.16, 0.24, 0.29
and 0.32) respectively (Fig. 1). Elaeodendron croceum
and C. aurea had only one active band against S. aureus.
An antimicrobial compound with Rf value 0.12 was
present in all of the plant extracts, indicating that the
same compound is probably present in all the extracts
(Fig. 1).
Minimal inhibitory concentration and total antibacterial
activity
The serial microdilution results were analysed using the
Analysis of Variance (ANOVA) single factor statistical
tool indicated that there is a significant difference in the
sensitivity of the tested microorganisms to the various
extracts (ρ < 0.01). The MICs ranged from 0.02 ± 0.00 to
0.52 ± 0.15 mg/ml (Tables 1, 2 and Fig. 2). The microbial
sensitivity to the different extracts represented by the
mean MIC values ranged from 0.09 to 0.28 mg/ml
(Fig. 3). Escherichiacoli, a Gram-negative bacterium was
as expected from the basis of selection the most sensi-
tive species (MIC = 0.09 mg/ml), followed by S. aureus
(MIC = 0.20 mg/ml), S. Typhimurium (MIC = 0.22 mg/ml)
and E. faecalis (MIC = 0.28 mg/ml) (Fig. 3).
The overall sensitivity of E.coli confirmed the activities
obtained in previous screening against the E.coli [13].
Also, Makhafola and Eloff [26] in their preliminary in-
vestigation of the antibacterial activity of crude acetone
extracts of Ochna spp. reported that E.coli was the most
sensitive bacterial species amongst the tested bacteria. In
this study, the mean MIC values of the extracts against
E. faecalis and S. Typhimurium were statistically signifi-
cantly higher than the MIC value of the extracts against
E. coli (ρ < 0.01) (Fig. 3). Nkuo-Akenj et al. (2001) in
Aliero and Ibrahim [27] reported that S. Typhimurium
was the least sensitive to the extracts of Commelina
bengalensis, with MIC value of 1 mg/ml, and required a
concentration of 4 mg/ml to be bactericidal. The resist-
ance of S. Typhimurium is of public health concern, as
major salmonellosis outbreaks are caused by the emer-
gence of antibiotic resistant Salmonella spp. as a result
of the use of antimicrobial growth promoters in animals
used as food [27].
Overall, the Gram-negative bacteria were more sensi-
tive to the extracts than the Gram-positive bacteria
(Tables 1, 2 and Figs. 2 and 3) but the differences were
not statistically significant (p > 0.05). These results are in
agreement with our earlier findings on compounds
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isolated from Ochna species [28]. The difference in the
sensitivity between Gram-negative and Gram-positive
bacteria may be due to the variation in their cell wall
structure. The Gram-positive bacterial cell wall consists
of 70–100 layers of peptidoglycans. Peptidoglycan is
comprised of two polysaccharides, N-acetyl-glucosamine
and N-acetyl-muramic acid cross-linked by peptide side
chains and cross bridges. This is certainly an oversimpli-
fication as an explanation and other mechanisms prob-
ably play a role. Resistance from Gram-negative bacteria
against antibiotics like penicillin originates from the se-
cretion of the lactamase enzyme in the periplasmic space
between the thin outer membrane and the cytoplasmic
membrane [29].
The mean difference between the MIC values of the
extracts against all tested pathogens was statistically sig-
nificant (ρ < 0.05). The mean MIC of H. arborescens
(0.335 mg/ml) was significantly higher than the extract
of M. lanceolata (0.098 mg/ml), ρ < 0.01. Heteromorpha
arborescens was the least active extract and M. lanceolata
the most potent extract (Fig. 4). Maesa lanceolata, M.
mesozygia and C. aurea had good activity against Gram-
negative bacteria, mean MIC = 0.09 ± 0.06, 0.10 ± 0.05 and
0.11 ± 0.06 mg/ml respectively. Cremaspora triflora, M.
lanceolata and M. mesozygia were more potent against all
the Gram-positive bacteria, mean MIC values = 0.07 ±
0.05, 0.10 ± 0.04 and 0.13 ± 0.05 mg/ml respectively.
Maesa lanceolata extracts had the same MIC value of
0.10 mg/ml against all pathogens making it the most ac-
tive extract (Fig. 2). Adamu et al. [25] determined the anti-
bacterial and antioxidant activities of 13 South African
plants extracts. They also found thatMaesa lanceolata ex-
tracts had higher activity against four nosocomial bacteria
than other plant extracts.
The average MIC of the different extracts against
Staphylococcus aureus was 0.2 mg/ml, with a standard
deviation of 0.17 (Table 2). There was a wide range of
MICs amongst the different extracts against Staphylococcus
aureus. Cremaspora triflora had the lowest MIC of
0.02 mg/ml, while Heteromorpha arborescens had a high
Table 1 Extract yield, Minimal Inhibitory Concentration (MIC) with standard deviation and Total Antibacterial Activity (TAA) of the
nine selected acetone leaf extracts against Gram-negative test bacteria
Escherichia coli Salmonella Typhimurium Pseudomonas aeruginosa
Plants % yield MIC (mg/ml) TAA (ml/g) MIC (mg/ml) TAA (ml/g) MIC (mg/ml) TAA (ml/g)
Hypericum roeperianum 12.0 0.13 ± 0.04 922.82 0.26 ± 0.07 461.41 0.08 1499.58
Cremaspora triflora 2.02 0.05 ± 0.02 403.33 0.32 ± 0.25 63.02 0.16 126.04
Heteromorpha arborescens 2.60 0.18 ± 0.10 144.63 0.31 ± 0.00 83.98 0.16 162.71
Pittosporum viridiflorum 2.72 0.11 ± 0.04 246.97 0.22 ± 0.13 123.48 0.16 169.79
Bolusanthus speciosus 2.30 0.08 ± 0.00 287.92 0.13 ± 0.04 177.18 0.16 143.96
Calpurnia aurea 2.86 0.04 ± 0.00 715.83 0.13 ± 0.04 220.26 0.16 178.96
Maesa lanceolata 11.12 0.04 ± 0.00 2780.83 0.16 ± 0.00 695.21 0.08 1390.42
Elaeodendron croceum 9.00 0.11 ± 0.04 817.88 0.26 ± 0.07 346.03 0.08 1124.58
Morus mesozygia 1.85 0.07 ± 0.02 263.81 0.16 ± 0.11 115.42 0.08 230.83
Gentamicin NA 0.0008 NA 0.0002 NA 0.0002 NA
Average for extracts NA 0.09 ± 0.04 NA 0.22 ± 0.07 NA 0.12 ± 0.04 NA
NA not applicable
Fig. 1 a Chromatogram developed in Benzene: Ethanol: Ammonia (BEA) solvent system of the different plant leaf acetone extracts sprayed with
vanillin. b Bioautography of Staphylococcus aureus developed with BEA; white bands indicate compounds that inhibit the growth of the bacteria.
HR = Hypericum roeperianum, CT = Cremaspora triflora, HA = Heteromorpha arborescens, PV = Pittosporum viridiflorum, BS = Bolusanthus speciosus,
CA = Calpurnia aurea, ML =Maesa lanceolata, EC = Elaeodendron croceum, MM =Morus mesozygia
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MIC of 0.52 mg/ml. In all, there was a no statistically sig-
nificant difference in average MIC of the different extracts
against all tested Gram-positive bacteria (Table 2). The ex-
tracts had lower average MICs values against all tested
Gram-negative bacteria compared with Gram-positive bac-
teria. The extracts had an average MIC of 0.09 mg/ml
against E. coli and a higher MIC value of 0.22 mg/ml
against Salmonella Typhimurium. The standard deviation
of the mean MIC values of the different extracts was low
compared to that of the Gram-positive bacteria. Cremas-
pora triflora extracts had good MIC values of 0.02 mg/ml
and 0.05 mg/ml against both Staphylococcus aureus
(Gram-positive) and Escherichia coli (Gram-negative) re-
spectively. The average MIC value of the different extracts
against Gram-negative and Gram-positive bacteria was
0.14 mg/ml and 0.21 mg/ml respectively. Standard devi-
ation of the means was 0.04, and differences were not
statistically significant. It may be interpreted that the
different extracts have similar activity against both
Gram-negative and Gram-positive bacteria, giving them
a broader spectrum.
The total antibacterial activity (TAA), is a function of
the extraction yield in milligram per 1 gram of plant ma-
terial and the minimal inhibitory concentration (MIC),
expressed in millilitre per gram (ml/g) [30]. TAA indi-
cates the volume of water or solvent, when added to 1
gram of the extract that will still inhibit the growth of
the pathogen [30]. There was a statistically significant
difference between the efficacy of the extracts against
the tested microorganisms (ρ < 0.01). Maesa lanceolata,
Table 2 Extract yields, Minimal Inhibitory Concentration (MIC) and Total Antibacterial Activity of the nine selected acetone leaf
extracts against Gram-positive bacteria
Staphylococcus aureus Enterococcus faecalis Bacillus cereus
Plants % yield MIC (mg/ml) TAA (ml/g) MIC (mg/ml) TAA (ml/g) MIC (mg/ml) TAA (ml/g)
Hypericum roeperianum 12.0 0.23 ± 0.11 521.59 0.32 ± 0.22 374.90 0.06 ± 0.03 1999.44
Cremaspora triflora 2.02 0.02 ± 0.00 1008.33 0.12 ± 0.14 168.06 0.08 ± 0.00 252.08
Heteromorpha arborescens 2.60 0.52 ± 0.15 50.06 0.42 ± 0.15 61.98 0.42 ± 0.15 61.98
Pittosporum viridiflorum 2.72 0.08 ± 0.00 339.58 0.42 ± 0.15 64.68 0.21 ± 0.07 129.37
Bolusanthus speciosus 2.30 0.45 ± 0.26 51.19 0.31 ± 0.00 74.30 0.11 ± 0.04 209.39
Calpurnia aurea 2.86 0.12 ± 0.06 238.61 0.21 ± 0.07 136.35 0.11 ± 0.04 260.30
Maesa lanceolata 11.12 0.06 ± 0.03 1853.89 0.13 ± 0.13 855.64 0.12 ± 0.14 926.94
Elaeodendron croceum 9.00 0.23 ± 0.11 391.16 0.42 ± 0.15 214.21 0.21 ± 0.07 428.41
Morus mesozygia 1.85 0.08 ± 0.00 230.83 0.16 ± 0.11 115.42 0.16 ± 0.11 115.42
Gentamicin NA 0.002 NA 0.0016 NA 0.0002 NA
Average for extracts NA 0.20 ± 0.17 NA 0.28 ± 0.12 NA 0.12 ± 0.04 NA
NA not applicable
Fig. 2 Average MIC values of the nine-acetone leaf extracts against all the test bacteria; the lower the MIC values the most potent the extract.
There is a significant difference between the MIC values of the different crude extracts against the test bacteria (ρ < 0.05). HR = Hypericum roeperianum,
CT = Cremaspora triflora, HA = Heteromorpha arborescens, PV = Pittosporum viridiflorum, BS = Bolusanthus speciosus, CA= Calpurnia aurea, ML =Maesa
lanceolata, EC = Elaeodendron croceum, MM=Morus mesozygia
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H. roeperianum and E. croceum had higher activities in
the antibacterial assay, with TAA values of 1417, 963 and
554 ml/g respectively (Fig. 5). The MIC and TAA values
are useful pharmacological tools in determining the activity
of extracts in mg/ml (potency) of plants extracts for isolat-
ing bioactive compounds and total activity on ml/g
(efficacy) is useful for the selection of plant species [30].
Cytotoxicity and safety of the extracts
To assume that crude plant extracts or natural products
are safe for use could be misleading and dangerous [28].
There were differences in the cytotoxicity of the different
extracts (Table 3). Heteromorpha arborescens extracts had
the lowest toxicity with LC50 = 81.0 ± 7.6 μg/ml, followed
by H. roeperianum (66.2 ± 0.02 μg/ml) and C. triflora
(57.4 ± 2.94 μg/ml). Plant extracts with LC50 ≤ 20 μg/ml
are considered toxic [31]. M. lanceolata had the lowest
LC50 at 2.38 ± 0.25 μg/ml, and was even more toxic than
the reference drug doxorubicin at 8.3 ± 1.76 μg/ml [32].
Our report on the cytotoxicity of M. lanceolata agrees
with the reports of Adamu et al. [33] and Muhammad
et al. [34]. In addition, crude saponins isolated from the
stem bark of M. lanceolata are toxic to snails at a concen-
tration of 1 μg/ml and potentially harmful to aquatic biota
[35]. Plant extracts that are more toxic to the cells than to
bacteria may have no therapeutic value. It is also possible
that the cytotoxicity may be due to a general metabolic
toxin affecting microorganisms and animal cells. [28].
However, it might be erroneous to draw a conclusion on
the cytotoxicity and usefulness of a plant extract by using
one or even several cell lines. The toxicity should also be
determined in in vivo studies before a definitive conclu-
sion can be reached. Discarding a crude extract because of
initial cytotoxic effects on cell lines might be unproduct-
ive. The cytotoxic compound may not necessarily be the
antibacterial compound. It is at least theoretically possible
to isolate a potent, non-toxic novel metabolite from toxic
crude plant extracts.
Fig. 3 The mean MIC in mg/ml of the acetone leaf extracts of the nine plants against five different bacteria. SA = Staphylococcus aureus, EF =
Enterococcus faecalis, BC = Bacillus cereus, EC = Escherichia coli, ST = Salmonella Typhimurium, PA = Pseudomonas aeruginosa, a = Enterococcus faecalis
and Escherichia coli (ρ < 0.01), b = Salmonella Typhimurium and Escherichia coli (ρ < 0.01)
Fig. 4 The mean MIC in mg/mlof the acetone leaf extracts of nine plants against all the test bacteria (ρ < 0.05). HR = Hypericum roeperianum,
CT = Cremaspora triflora, HA = Heteromorpha arborescens, PV = Pittosporum viridiflorum, BS = Bolusanthus speciosus, CA = Calpurnia aurea,
ML =Maesa lanceolata, EC = Elaeodendron croceum, MM =Morus mesozygia, * = mean MIC value of H. arborescens is significantly higher than
MIC of M. lanceolata (ρ < 0.01)
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The selectivity index (SI) is calculated by dividing the
LC50 in mg/ml by the MIC in mg/ml of the test bacteria.
The higher the SI value the safer the extracts may be. Se-
lectivity index values greater than one suggests that extracts
are less toxic to the host cell than the bacteria [28]. Cremas-
pora triflora had the best SI against S. aureus (2.87) and E.
coli (1.15) while H. roeperianum had SI of 1.15 against B.
cereus (Table 3). The MIC of the extracts was compared
with their cytotoxicity for any noticeable correlation. In all,
there was a weak, positive correlation (R = 0.45), which was
statistically not significant (ρ > 0.05). This probably means
that in many cases the cytotoxicity was not caused by the
same compounds responsible for the antimicrobial activity
on both the Gram-positive and Gram-negative bacteria.
Conclusion
Some of the extracts had a good potential for therapeutic
uses against some pathogens. It appears that extracts with
high antimicrobial activity against Gram-negative bacteria
do not necessarily have high activity against other Gram–
negative bacteria compared to Gram-positive bacteria. This
may mean that the activity is not related to the differences
in cell wall structure. Because there is such a wide range of
MICs for different strains of the same bacterial species, it is
dangerous to generalize these results for one strain of each
of the bacteria although these strains were the strains rec-
ommended by the National Committee for Clinical Labora-
tory Standards to compare different antibiotics.
Further investigation is underway on the two species
C. triflora and H. roeperianum that had promising po-
tency and safety. The potency of many of the extracts on
the test bacteria was apparently not due to the presence
of a general metabolic toxin but possibly through an-
other mechanism of action. It may be interesting to in-
vestigate the mode of action of the extracts against test
bacteria and resistant clinical strains.
Fig. 5 Efficacy (mean TAA values, ml/g) of the different acetone extracts against all the test bacteria. The higher the TAA value, the more efficacious
the plant. The quantity extracted from 1 g of CL can be diluted to 1417 ml and will still inhibit on average the different bacteria. HR = Hypericum
roeperianum, CT = Cremaspora triflora, HA = Heteromorpha arborescens, PV = Pittosporum viridiflorum, BS = Bolusanthus speciosus, CA = Calpurnia aurea,
ML =Maesa lanceolata, EC = Elaeodendron croceum, MM=Morus mesozygia
Table 3 Cytotoxicity against Vero cells LC50 (μg/ml) from Elisha et al., [32] and Selectivity Index of the nine selected acetone
crude extracts
Selectivity index
Plants Cytotoxicity S. aureus E. faecalis B. cereus E. coli P. aeruginosa S. typhimurium Average
Hypericum roeperianum 66.2 ± 0.02 0.29 0.21 1.10 0.51 0.83 0.25 0.53
Cremaspora triflora 57.4 ± 2.94 2.87 0.48 0.72 1.15 0.36 0.18 0.96
Heteromorpha arborescens 81.0 ± 7.6 0.16 0.19 0.19 0.45 0.51 0.26 0.29
Pittosporum viridiflorum 54.6 ± 14.3 0.68 0.13 0.26 0.50 0.34 0.25 0.36
Bolusanthus speciosus 52.8 ± 3.92 0.12 0.17 0.48 0.66 0.33 0.41 0.36
Calpurnia aurea 13.6 ± 2.26 0.11 0.06 0.12 0.34 0.09 0.10 0.14
Maesa lanceolata 2.38 ± 0.25 0.04 0.02 0.02 0.06 0.03 0.01 0.03
Elaeodendron croceum 5.2 ± 0.24 0.02 0.01 0.02 0.05 0.07 0.02 0.03
Morus mesozygia 40.7 ± 1.54 0.51 0.25 0.25 0.58 0.51 0.25 0.39
Doxorubicin 8.3 ± 1.76 ND ND ND ND ND ND ND
ND not determined
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Abbreviations
DMSO: Dimethyl Sulphoxide; INT: ρ-iodonotrotetrazolium violet; LC50: Lethal
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bromide; PBS: Phosphate buffer saline; SD: Standard deviation; SI: Selectivity
index; TAA: Total antibacterial activity
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